Skip to main content
. Author manuscript; available in PMC: 2015 Nov 12.
Published in final edited form as: Clin Immunol. 2010 Dec 3;138(2):201–211. doi: 10.1016/j.clim.2010.11.002

Table 3.

Lenalidomide effects on LPS-stimulated macrophage generation of TNF-α.

Concentration of lenalidomide (nM)
(percentage of control, mean±S.D.)
10 30 100 300 1000
Incubation time (h)
6 91 ±14 78±13 67±7.8* 65±4.5** 46 ±14*
24 69±11* 54±17* 35 ±4.0** 33±1.5** 20±4.5**
48 73 ±12 57±2.5** 48±3.2** 36±4.6** 36 ±7.6**

Each value is the mean +S.D. of the results from studies of two adults of ages 21–45 and two adults of ages N65 years. Production of TNF-α evoked by 100 ng/ml of LPS in the absence of lenalidomide (100% control) ranged from 4439 to 6039 pg/ml, 1843 to 2038 pg/ml, and 222 to 308 pg/ml after 6, 24 and 48 h of incubation. The significance of decreases in TNF-α generation induced by lenalidomide relative to the control (100%) value were calculated by a two-sample t test;

+

=pb0.05,

*

=pb0.01 and

**

=pb0.001.